SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Joe King who wrote (7849)1/20/1998 11:48:00 AM
From: vegetarian  Read Replies (2) | Respond to of 14328
 
Not surprised because company has not said how much the deal would add to the revenue bottomline or whether their old HIV tests will simply be replaced by the new ones presently.
When they don't talk about revenues, the investors are not excited.



To: Joe King who wrote (7849)1/20/1998 3:31:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 14328
 
Joe, CNBC has been talking about the AHP/SBH merger all day. I have put up
several synopsi as well as WSJ and Financial Times reports. They are linked to the
Alliance section (under SBH and AHP) of Ligand Links (
home.att.net ).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News